Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer

P. Pfeiffer; S. Winther; M. Yilmaz; S. Moller; D. Zitnjak; L. Poulsen; K. Thomsen; C. Qvortrup

doi:10.1016/j.annonc.2020.04.463

Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer

P. Pfeiffer, S. Winther, M. Yilmaz, S. Moller, D. Zitnjak, L. Poulsen, K. Thomsen, C. Qvortrup

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	PD-7
Tidsskrift	Annals of Oncology
Vol/bind	31
Udgave nummer	3
Sider (fra-til)	S214
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2020.04.463
Status	Udgivet - 1. jul. 2020
Begivenhed	ESMO 22nd World Congress on Gastrointestinal Cancer (Virtual) - Varighed: 1. jul. 2020 → 4. jul. 2020

Konference

Konference	ESMO 22nd World Congress on Gastrointestinal Cancer (Virtual)
Periode	01/07/2020 → 04/07/2020

Dokumenter og links

10.1016/j.annonc.2020.04.463Licens: Andet

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Pfeiffer, P., Winther, S., Yilmaz, M., Moller, S., Zitnjak, D., Poulsen, L., Thomsen, K., & Qvortrup, C. (2020). Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer. Annals of Oncology, 31(3), S214. Artikel PD-7. https://doi.org/10.1016/j.annonc.2020.04.463

@article{a9f2d750dd56432db3cba3b268d430fd,

title = "Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer",

author = "P. Pfeiffer and S. Winther and M. Yilmaz and S. Moller and D. Zitnjak and L. Poulsen and K. Thomsen and C. Qvortrup",

year = "2020",

month = jul,

day = "1",

doi = "10.1016/j.annonc.2020.04.463",

language = "English",

volume = "31",

pages = "S214",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "3",

note = "ESMO 22nd World Congress on Gastrointestinal Cancer (Virtual)<br/> ; Conference date: 01-07-2020 Through 04-07-2020",

}

Pfeiffer, P, Winther, S, Yilmaz, M, Moller, S, Zitnjak, D, Poulsen, L, Thomsen, K & Qvortrup, C 2020, 'Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer', Annals of Oncology, bind 31, nr. 3, PD-7, s. S214. https://doi.org/10.1016/j.annonc.2020.04.463

Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer. / Pfeiffer, P.; Winther, S.; Yilmaz, M. et al.
I: Annals of Oncology, Bind 31, Nr. 3, PD-7, 01.07.2020, s. S214.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer

AU - Pfeiffer, P.

AU - Winther, S.

AU - Yilmaz, M.

AU - Moller, S.

AU - Zitnjak, D.

AU - Poulsen, L.

AU - Thomsen, K.

AU - Qvortrup, C.

PY - 2020/7/1

Y1 - 2020/7/1

U2 - 10.1016/j.annonc.2020.04.463

DO - 10.1016/j.annonc.2020.04.463

M3 - Conference abstract in journal

SN - 0923-7534

VL - 31

SP - S214

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

M1 - PD-7

T2 - ESMO 22nd World Congress on Gastrointestinal Cancer (Virtual)<br/>

Y2 - 1 July 2020 through 4 July 2020

ER -